Health archive

Eradicating malaria

Eradicating malaria November 21, 2012:

Taking aim at the global health problem of malaria, which infects 250 million people worldwide every year and kills one child every 45 seconds in Africa alone, UC Berkeley researchers in the frontier field of synthetic biology re-engineered yeast to produce the antimalarial drug artemisinin. The development of this semi-synthetic compound through cutting-edge research and public-private collaboration ensures an affordable, […]

Hepatitis vaccine

Hepatitis vaccine February 21, 2012:

Building on his work at Berkeley, biochemistry professor Edward Penhoet co-founded Chiron in 1981 to develop diagnostic tools and biopharmaceuticals to tackle a range of diseases and conditions, including cancer, HIV, malaria, multiple sclerosis and cystic fibrosis. Best known for its work discovering the virus that causes hepatitis C and the subsequent development of screening methods to reduce the risk […]

Molecular mechanics of disease

Molecular mechanics of disease January 30, 2012:

The research of Robert Tjian, professor of molecular and cell biology, has provided new insights into the molecular mechanisms that underlie a host of human diseases and conditions from Huntington’s disease and cancer to diabetes and infertility. Seeking to understand how genes are controlled inside the cell, Tjian’s work focuses on proteins that regulate the expression of genes and their […]

Punching holes in tumor cells

Punching holes in tumor cells January 17, 2012:

Berkeley engineers developed a way to destroy cell walls without harming nearby tissue vessels, a breakthrough that has since become a surgical technique that attacks difficult-to-remove tumors. In 2008, UC Berkeley licensed the irreversible electroporation (IRE) technology to medical device manufacturer AngioDynamics for use in its NanoKnife System. The minimally invasive surgical system, which uses microsecond electrical pulses to punch […]

A cancer treatment

A cancer treatment October 19, 2011:

The National Academy of Sciences proclaimed UC Berkeley Cancer Research Lab’s groundbreaking isolation and blockade of the T-cell antigen CTLA-4 “one of the three most important findings in immunology in the last 20 years.” The discovery led to the development of an immunotherapy that boosts the effectiveness of a number of cancer vaccines. Now FDA-approved for the treatment of advanced […]